Key result
Ionic-liquid-related salts 5 and 4 demonstrate ~71% antioxidant scavenging and superior MCF-7 anticancer activity.
Why the study?
The study aimed to develop effective functional ionic-liquid-related salts as future anticancer drugs.
Synthesized imidazole-based ionic-liquid-related salts (ILRSs 5 and 4) demonstrate promising in vitro antioxidant and anticancer properties, suggesting potential for future drug development.
ILRSs 5 and 4 merit further preclinical testing as anticancer candidates; leaves open in vivo efficacy and clinical translation.
Aims To develop effective functional ionic-liquid-related salts (ILRSs) as future anticancer drugs.Materials and Methods Twelve imidazole-based ionic-liquid-related salts were synthesized and characterized by spectroscopic methods. These ILRSs were used to study the antioxidant and anticancer activities, DNA titration, modeling, and in-silico studies.Results Among 12 ILRSs, ILRSs 5 and 4 indicated superior activities, showing higher scavenging percentages (70.7% and 65.5%) and lower IC50 values than the standard ascorbic acid. ILRSs 5 and 4 showed the most effective activities with MCF-7 cells, with viability values of 52.17% and 53.67% at 10 µM and IC50 values of 10.87 and 11.03 µM, respectively. DNA-binding studies showed moderate to strong interactions with Ct-DNA (binding constants: 104 to 105 M−1). The modeling studies of compounds A and B with DNA confirmed one hydrogen bond with −8.7 and −8.2 kcal/mol binding affinities.Conclusions The reported ILRSs 5 and 4 showed good antioxidant and anticancer activities and may be used as future anticancer drugs.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied Cancer. Imidazole-based ionic-liquid-related salts (ILRSs 5 and 4) vs. Ascorbic acid was evaluated on Antioxidant scavenging percentage and MCF-7 cell viability. Ionic-liquid-related salts 5 and 4 demonstrated superior antioxidant scavenging (70.7% and 65.5%) and anticancer activity against MCF-7 cells (viability 52.17% and 53.67% at 10 µM).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: